Virtual Evolution: A Conference for Women by Women
Videos
Virtual Evolution: A Conference for Women by Women
Selecting Treatment Options for 1L mNSCLC: IO Mono, IO/IO, or Chemo/IO?
- 161 views
- December 10, 2020
- 1
Virtual Evolution: A Conference for Women by Women
59 y/o Woman With HER2+ MBC, Progression in the Liver and New Mets in the Bilateral Lungs: What RT and Systemic Options Do We Have?
FEATURING
Jennifer Crozier,
Mayra Lima,
Reshma L. Mahtani,
Kristina Mirabeau-Beale,
Maria Rueda-Lara
- 276 views
- December 8, 2020
- 1
Virtual Evolution: A Conference for Women by Women
59 y/o Woman With Invasive Ductal Carcinoma, Grade 3, HER2 Is 3+: Should We Consider for Preoperative Systemic Therapy? What Are the Recommended Neo(adjuvant) Regimens?
FEATURING
Jennifer Crozier,
Mayra Lima,
Reshma L. Mahtani,
Kristina Mirabeau-Beale,
Maria Rueda-Lara
- 45 views
- December 8, 2020
Virtual Evolution: A Conference for Women by Women
59 y/o Woman With HER2+ Invasive Ductal Carcinoma Who Received 6 Cycles of Neoadjuvant TCHP: Which Post-Neoadjuvant Systemic Option to Consider? What Are RT Options?
FEATURING
Jennifer Crozier,
Mayra Lima,
Reshma L. Mahtani,
Kristina Mirabeau-Beale,
Maria Rueda-Lara
- 15 views
- December 8, 2020